Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Equity (2021 - 2025)

Journey Medical (DERM) has disclosed Return on Equity for 5 consecutive years, with 0.38% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity rose 127.0% year-over-year to 0.38%, compared with a TTM value of 0.38% through Sep 2025, up 127.0%, and an annual FY2024 reading of 0.73%, down 52.0% over the prior year.
  • Return on Equity was 0.38% for Q3 2025 at Journey Medical, up from 0.42% in the prior quarter.
  • Across five years, Return on Equity topped out at 2.98% in Q3 2021 and bottomed at 10.46% in Q2 2023.
  • Average Return on Equity over 5 years is 1.42%, with a median of 1.09% recorded in 2022.
  • The sharpest move saw Return on Equity tumbled -938bps in 2023, then soared 1053bps in 2024.
  • Year by year, Return on Equity stood at 2.9% in 2021, then surged by 53bps to 1.37% in 2022, then skyrocketed by 85bps to 0.2% in 2023, then plummeted by -362bps to 0.94% in 2024, then soared by 60bps to 0.38% in 2025.
  • Business Quant data shows Return on Equity for DERM at 0.38% in Q3 2025, 0.42% in Q2 2025, and 0.4% in Q1 2025.